0001437749-17-000782.txt : 20170216 0001437749-17-000782.hdr.sgml : 20170216 20170118170919 ACCESSION NUMBER: 0001437749-17-000782 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 CORRESP 1 filename1.htm prog20170118b_corresp.htm

January 18, 2017

 

VIA EDGAR

 

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549-3628

 

Re:

Progenics Pharmaceuticals, Inc. (the “Company”) – Request for Acceleration

  Registration Statement on Form S-3 Filed January 6, 2017 (File No. 333-215454)

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, as amended, requesting effectiveness for 4:30 p.m. Eastern Time on January 19, 2017, or as soon thereafter as is practicable.

 

 

Very truly yours,

CANTOR FITZGERALD & CO.

 

 

By: /s/ Jeffrey Lumby                                         

Name:     Jeffrey Lumby

Title:       Senior Managing Director